Development of colonic adenocarcinomas in a mouse model of ulcerative colitis.

Mice deficient in both interleukin-2 and beta 2-microglobulin expression (Beta 2mullnull x IL-2null mice) develop an inflammatory disease of the colon resembling ulcerative colitis. To examine long-term complications of disease in these mice, a group of 34 Beta 2mnull x IL-2null mice was monitored for 6-12 months. Development of clinical disease was assessed by wasting, general appearance, and diarrhea. Further analysis included histologic examination of the distal colon for colitis, staining of CD4+ T cells for surface activation markers, and cytoplasmic staining of CD4+ T cells for IFN-gamma and TNF-alpha. These older Beta 2mnull x IL-2null mice had activated CD4+ T cells as assessed by surface markers on flow cytometry. Cytoplasmic staining revealed IFN-gamma production, but not TNF-alpha production by CD4+ T cells. The majority of these older Beta 2mnull x IL-2null mice continued to have colitis on histology. However, they lived much longer and had less wasting in comparison to IL-2null mice. At necropsy, 11 (32%) of 34 of the Beta 2mnull x IL-2null mice had tumors in the proximal half of the colon. Histologic examination confirmed these tumors to be adenocarcinomas. These mice may be useful as a model for studying carcinogenesis in chronic colitis.

[1]  H. Goldman.  Significance and detection of dysplasia in chronic colitis , 1996, Cancer.

[2]  W. Bodmer,et al.  Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomas , 1996, Current Biology.

[3]  M. Leach,et al.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. , 1996, The Journal of clinical investigation.

[4]  J. Hardcastle,et al.  Screening high-risk groups for colorectal neoplasia. , 1996, The American journal of gastroenterology.

[5]  A. Forbes,et al.  Mismatch repair function and neoplasia in ulcerative colitis. , 1996, Gastroenterology.

[6]  J. Gordon,et al.  Inflammatory Bowel Disease and Adenomas in Mice Expressing a Dominant Negative N-Cadherin , 1995, Science.

[7]  D. Allen,et al.  Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin‐2‐deficient colitis , 1995, European journal of immunology.

[8]  R. Sartor.  Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. , 1995, Gastroenterology clinics of North America.

[9]  F. Chan,et al.  A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. , 1995, Immunity.

[10]  S. Simpson,et al.  Severe colitis in mice with aberrant thymic selection. , 1995, Immunity.

[11]  S. Itzkowitz.  Colon Carcinogenesis in Inflammatory Bowel Disease: Applying Molecular Genetics to Clinical Practice , 1995, Inflammatory bowel diseases.

[12]  A. Bradley,et al.  Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice , 1995, Nature Genetics.

[13]  R. Sartor.  Insights into the pathogenesis of inflammatory bowel diseases provided by new rodent models of spontaneous colitis , 1995 .

[14]  E. Mizoguchi,et al.  New models of chronic intestinal inflammation , 1994 .

[15]  P. Prior,et al.  Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. , 1994, Gut.

[16]  R. Coffman,et al.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. , 1994, Immunity.

[17]  W. Bodmer,et al.  Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Coffman,et al.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.

[19]  S. Tonegawa,et al.  Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice , 1993, Cell.

[20]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[21]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[22]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[23]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[24]  D. Seidner,et al.  The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. , 1997, Gastroenterology.

[25]  S. Simpson,et al.  Defects in T-Cell Regulation , 1996 .